Use App
AI Agent
Trending
News
Earnings
All
DIA
1.24%
SPY
0.52%
QQQ
0.01%
Trending
TDOC
0.32%
FMC
0.60%
LLY
2.54%
SMH
0.74%
HIMX
2.16%
OXY
2.67%
HRL
1.40%
PR
4.47%
DXYZ
2.31%
CAT
2.42%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
MDNAF
news
Exchange:
OTC
·
Updated 03:03 PM EDT
MDNAF News
News
all
press releases
Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know
Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
1
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile